荣昌生物：2025年第一季度净亏损2.54亿元

Group 1 - The core point of the article is that Rongchang Bio reported a revenue of 526 million yuan in the first quarter of 2025, representing a year-on-year increase of 59.17% [1] - The company incurred a net loss of 254 million yuan, which is an improvement compared to a net loss of 349 million yuan in the same period last year [1]